#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	ana	3-1

#Text=Fungal infections are generally perceived as being relatively uncommon , yet are reported to affect more than a billion people .
2-1	16-22	Fungal	abstract[2]	new[2]	coref	4-1[9_2]
2-2	23-33	infections	abstract[2]	new[2]	_	_
2-3	34-37	are	_	_	_	_
2-4	38-47	generally	_	_	_	_
2-5	48-57	perceived	_	_	_	_
2-6	58-60	as	_	_	_	_
2-7	61-66	being	_	_	_	_
2-8	67-77	relatively	_	_	_	_
2-9	78-86	uncommon	_	_	_	_
2-10	87-88	,	_	_	_	_
2-11	89-92	yet	_	_	_	_
2-12	93-96	are	_	_	_	_
2-13	97-105	reported	_	_	_	_
2-14	106-108	to	_	_	_	_
2-15	109-115	affect	_	_	_	_
2-16	116-120	more	person[3]	new[3]	_	_
2-17	121-125	than	person[3]	new[3]	_	_
2-18	126-127	a	person[3]	new[3]	_	_
2-19	128-135	billion	person[3]	new[3]	_	_
2-20	136-142	people	person[3]	new[3]	_	_
2-21	143-144	.	_	_	_	_

#Text=This is exacerbated when we consider the alarming global burden of antifungal resistance that we now experience .
3-1	145-149	This	abstract	giv	_	_
3-2	150-152	is	_	_	_	_
3-3	153-164	exacerbated	_	_	_	_
3-4	165-169	when	_	_	_	_
3-5	170-172	we	person	acc	ana	3-15
3-6	173-181	consider	_	_	_	_
3-7	182-185	the	abstract[6]	new[6]	_	_
3-8	186-194	alarming	abstract[6]	new[6]	_	_
3-9	195-201	global	abstract[6]	new[6]	_	_
3-10	202-208	burden	abstract[6]	new[6]	_	_
3-11	209-211	of	abstract[6]	new[6]	_	_
3-12	212-222	antifungal	abstract[6]|abstract[7]	new[6]|new[7]	coref	6-34[29_7]
3-13	223-233	resistance	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-14	234-238	that	abstract[6]	new[6]	_	_
3-15	239-241	we	abstract[6]|person	new[6]|giv	ana	4-3
3-16	242-245	now	abstract[6]	new[6]	_	_
3-17	246-256	experience	abstract[6]	new[6]	_	_
3-18	257-258	.	_	_	_	_

#Text=Many infections we believe to be of bacterial origin are in fact fungal .
4-1	259-263	Many	abstract[9]	giv[9]	coref	8-4[38_9]
4-2	264-274	infections	abstract[9]	giv[9]	_	_
4-3	275-277	we	abstract[9]|person	giv[9]|giv	ana	8-2
4-4	278-285	believe	abstract[9]	giv[9]	_	_
4-5	286-288	to	abstract[9]	giv[9]	_	_
4-6	289-291	be	abstract[9]	giv[9]	_	_
4-7	292-294	of	_	_	_	_
4-8	295-304	bacterial	abstract[11]	new[11]	_	_
4-9	305-311	origin	abstract[11]	new[11]	_	_
4-10	312-315	are	_	_	_	_
4-11	316-318	in	_	_	_	_
4-12	319-323	fact	_	_	_	_
4-13	324-330	fungal	_	_	_	_
4-14	331-332	.	_	_	_	_

#Text=Indeed , the yeast Candida albicans is a ubiquitous human commensal , but with opportunistic tendencies .
5-1	333-339	Indeed	_	_	_	_
5-2	340-341	,	_	_	_	_
5-3	342-345	the	substance[12]|person[13]	new[12]|new[13]	coref|coref	5-8[15_13]|6-7[0_12]
5-4	346-351	yeast	substance[12]|person[13]	new[12]|new[13]	_	_
5-5	352-359	Candida	person[13]	new[13]	_	_
5-6	360-368	albicans	person[13]	new[13]	_	_
5-7	369-371	is	_	_	_	_
5-8	372-373	a	abstract[14]|person[15]	new[14]|giv[15]	ana	6-1[0_14]
5-9	374-384	ubiquitous	abstract[14]|person[15]	new[14]|giv[15]	_	_
5-10	385-390	human	abstract[14]|person[15]	new[14]|giv[15]	_	_
5-11	391-400	commensal	abstract[14]|person[15]	new[14]|giv[15]	_	_
5-12	401-402	,	person[15]	giv[15]	_	_
5-13	403-406	but	person[15]	giv[15]	_	_
5-14	407-411	with	person[15]	giv[15]	_	_
5-15	412-425	opportunistic	person[15]|abstract[16]	giv[15]|new[16]	_	_
5-16	426-436	tendencies	person[15]|abstract[16]	giv[15]|new[16]	_	_
5-17	437-438	.	_	_	_	_

#Text=Its capacity to morphologically transition from yeast to hyphal cells enables it to react dynamically , both in evasion of host immunity and in its ability to readily form biofilm structures that impact increased antifungal resistance .
6-1	439-442	Its	abstract|abstract[18]	giv|new[18]	ana|coref	6-12|6-25[26_18]
6-2	443-451	capacity	abstract[18]	new[18]	_	_
6-3	452-454	to	abstract[18]	new[18]	_	_
6-4	455-470	morphologically	abstract[18]	new[18]	_	_
6-5	471-481	transition	abstract[18]	new[18]	_	_
6-6	482-486	from	abstract[18]	new[18]	_	_
6-7	487-492	yeast	abstract[18]|substance	new[18]|giv	coref	14-4
6-8	493-495	to	abstract[18]	new[18]	_	_
6-9	496-502	hyphal	abstract[18]|object[20]	new[18]|new[20]	coref	19-8[121_20]
6-10	503-508	cells	abstract[18]|object[20]	new[18]|new[20]	_	_
6-11	509-516	enables	_	_	_	_
6-12	517-519	it	abstract	giv	ana	6-25
6-13	520-522	to	_	_	_	_
6-14	523-528	react	_	_	_	_
6-15	529-540	dynamically	_	_	_	_
6-16	541-542	,	_	_	_	_
6-17	543-547	both	abstract[22]	new[22]	_	_
6-18	548-550	in	abstract[22]	new[22]	_	_
6-19	551-558	evasion	abstract[22]	new[22]	_	_
6-20	559-561	of	abstract[22]	new[22]	_	_
6-21	562-566	host	abstract[22]|animal|abstract[24]	new[22]|new|new[24]	coref	7-21[35_0]
6-22	567-575	immunity	abstract[22]|abstract[24]	new[22]|new[24]	_	_
6-23	576-579	and	_	_	_	_
6-24	580-582	in	_	_	_	_
6-25	583-586	its	abstract|abstract[26]	giv|giv[26]	coref	19-5[120_26]
6-26	587-594	ability	abstract[26]	giv[26]	_	_
6-27	595-597	to	abstract[26]	giv[26]	_	_
6-28	598-605	readily	abstract[26]	giv[26]	_	_
6-29	606-610	form	abstract[26]|abstract	giv[26]|new	coref|none	18-13[112_0]|6-29[0_112]
6-30	611-618	biofilm	abstract[26]|object|abstract[28]	giv[26]|new|new[28]	coref	7-11
6-31	619-629	structures	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-32	630-634	that	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-33	635-641	impact	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-34	642-651	increased	abstract[26]|abstract[28]|abstract[29]	giv[26]|new[28]|giv[29]	_	_
6-35	652-662	antifungal	abstract[26]|abstract[28]|abstract[29]	giv[26]|new[28]|giv[29]	_	_
6-36	663-673	resistance	abstract[26]|abstract[28]|abstract[29]	giv[26]|new[28]|giv[29]	_	_
6-37	674-675	.	_	_	_	_

#Text=C. albicans frequently resides in the oral cavity as a biofilm forming microorganism , interacting with other oral microbiota and the host .
7-1	676-678	C.	plant[30]	new[30]	coref	13-1[80_30]
7-2	679-687	albicans	plant[30]	new[30]	_	_
7-3	688-698	frequently	_	_	_	_
7-4	699-706	resides	_	_	_	_
7-5	707-709	in	_	_	_	_
7-6	710-713	the	place[31]	new[31]	_	_
7-7	714-718	oral	place[31]	new[31]	_	_
7-8	719-725	cavity	place[31]	new[31]	_	_
7-9	726-728	as	_	_	_	_
7-10	729-730	a	animal[33]	new[33]	_	_
7-11	731-738	biofilm	object|animal[33]	giv|new[33]	coref	18-16[113_0]
7-12	739-746	forming	animal[33]	new[33]	_	_
7-13	747-760	microorganism	animal[33]	new[33]	_	_
7-14	761-762	,	_	_	_	_
7-15	763-774	interacting	_	_	_	_
7-16	775-779	with	_	_	_	_
7-17	780-785	other	animal[34]	new[34]	_	_
7-18	786-790	oral	animal[34]	new[34]	_	_
7-19	791-801	microbiota	animal[34]	new[34]	_	_
7-20	802-805	and	_	_	_	_
7-21	806-809	the	animal[35]	giv[35]	coref	19-12[0_35]
7-22	810-814	host	animal[35]	giv[35]	_	_
7-23	815-816	.	_	_	_	_

#Text=When we consider root canal infections , pathogenic yeasts have also been isolated from teeth associated with primary apical periodontitis and post-treatment disease .
8-1	817-821	When	_	_	_	_
8-2	822-824	we	person	giv	_	_
8-3	825-833	consider	_	_	_	_
8-4	834-838	root	place[37]|abstract[38]	new[37]|giv[38]	coref|coref	12-16[77_37]|13-10[82_38]
8-5	839-844	canal	place[37]|abstract[38]	new[37]|giv[38]	_	_
8-6	845-855	infections	abstract[38]	giv[38]	_	_
8-7	856-857	,	_	_	_	_
8-8	858-868	pathogenic	plant[39]	new[39]	coref	18-3[110_39]
8-9	869-875	yeasts	plant[39]	new[39]	_	_
8-10	876-880	have	_	_	_	_
8-11	881-885	also	_	_	_	_
8-12	886-890	been	_	_	_	_
8-13	891-899	isolated	_	_	_	_
8-14	900-904	from	_	_	_	_
8-15	905-910	teeth	object[40]	new[40]	coref	9-37[52_40]
8-16	911-921	associated	object[40]	new[40]	_	_
8-17	922-926	with	object[40]	new[40]	_	_
8-18	927-934	primary	object[40]|abstract[41]	new[40]|new[41]	coref	20-30[134_41]
8-19	935-941	apical	object[40]|abstract[41]	new[40]|new[41]	_	_
8-20	942-955	periodontitis	object[40]|abstract[41]	new[40]|new[41]	_	_
8-21	956-959	and	object[40]	new[40]	_	_
8-22	960-974	post-treatment	object[40]|abstract[42]	new[40]|new[42]	_	_
8-23	975-982	disease	object[40]|abstract[42]	new[40]|new[42]	_	_
8-24	983-984	.	_	_	_	_

#Text=Dental pulp is generally a sterile tissue containing nerves and vascular tissues that are connected to the surrounding periradicular tissues , though recent studies appear to suggest the presence of bacterial DNA in the pulp of pristine healthy teeth .
9-1	985-991	Dental	object[43]	new[43]	coref	9-4[44_43]
9-2	992-996	pulp	object[43]	new[43]	_	_
9-3	997-999	is	_	_	_	_
9-4	1000-1009	generally	object[44]	giv[44]	coref	9-34[51_44]
9-5	1010-1011	a	object[44]	giv[44]	_	_
9-6	1012-1019	sterile	object[44]	giv[44]	_	_
9-7	1020-1026	tissue	object[44]	giv[44]	_	_
9-8	1027-1037	containing	object[44]	giv[44]	_	_
9-9	1038-1044	nerves	object[44]|object	giv[44]|new	_	_
9-10	1045-1048	and	object[44]	giv[44]	_	_
9-11	1049-1057	vascular	object[44]|object[46]	giv[44]|new[46]	coref	9-17[47_46]
9-12	1058-1065	tissues	object[44]|object[46]	giv[44]|new[46]	_	_
9-13	1066-1070	that	object[44]|object[46]	giv[44]|new[46]	_	_
9-14	1071-1074	are	object[44]|object[46]	giv[44]|new[46]	_	_
9-15	1075-1084	connected	object[44]|object[46]	giv[44]|new[46]	_	_
9-16	1085-1087	to	object[44]|object[46]	giv[44]|new[46]	_	_
9-17	1088-1091	the	object[44]|object[46]|object[47]	giv[44]|new[46]|giv[47]	coref	10-12[56_47]
9-18	1092-1103	surrounding	object[44]|object[46]|object[47]	giv[44]|new[46]|giv[47]	_	_
9-19	1104-1117	periradicular	object[44]|object[46]|object[47]	giv[44]|new[46]|giv[47]	_	_
9-20	1118-1125	tissues	object[44]|object[46]|object[47]	giv[44]|new[46]|giv[47]	_	_
9-21	1126-1127	,	_	_	_	_
9-22	1128-1134	though	_	_	_	_
9-23	1135-1141	recent	abstract[48]	new[48]	_	_
9-24	1142-1149	studies	abstract[48]	new[48]	_	_
9-25	1150-1156	appear	_	_	_	_
9-26	1157-1159	to	_	_	_	_
9-27	1160-1167	suggest	_	_	_	_
9-28	1168-1171	the	abstract[49]	new[49]	_	_
9-29	1172-1180	presence	abstract[49]	new[49]	_	_
9-30	1181-1183	of	abstract[49]	new[49]	_	_
9-31	1184-1193	bacterial	abstract[49]|substance[50]	new[49]|new[50]	_	_
9-32	1194-1197	DNA	abstract[49]|substance[50]	new[49]|new[50]	_	_
9-33	1198-1200	in	abstract[49]|substance[50]	new[49]|new[50]	_	_
9-34	1201-1204	the	abstract[49]|substance[50]|object[51]	new[49]|new[50]|giv[51]	coref	10-1[53_51]
9-35	1205-1209	pulp	abstract[49]|substance[50]|object[51]	new[49]|new[50]|giv[51]	_	_
9-36	1210-1212	of	abstract[49]|substance[50]|object[51]	new[49]|new[50]|giv[51]	_	_
9-37	1213-1221	pristine	abstract[49]|substance[50]|object[51]|object[52]	new[49]|new[50]|giv[51]|giv[52]	_	_
9-38	1222-1229	healthy	abstract[49]|substance[50]|object[51]|object[52]	new[49]|new[50]|giv[51]|giv[52]	_	_
9-39	1230-1235	teeth	abstract[49]|substance[50]|object[51]|object[52]	new[49]|new[50]|giv[51]|giv[52]	_	_
9-40	1236-1237	.	_	_	_	_

#Text=The pulp is protected from the oral microbiome by layers of mineralised tissues ( dentin , enamel and cementum ) .
10-1	1238-1241	The	object[53]	giv[53]	coref	11-31[70_53]
10-2	1242-1246	pulp	object[53]	giv[53]	_	_
10-3	1247-1249	is	_	_	_	_
10-4	1250-1259	protected	_	_	_	_
10-5	1260-1264	from	_	_	_	_
10-6	1265-1268	the	substance[54]	new[54]	_	_
10-7	1269-1273	oral	substance[54]	new[54]	_	_
10-8	1274-1284	microbiome	substance[54]	new[54]	_	_
10-9	1285-1287	by	_	_	_	_
10-10	1288-1294	layers	substance[55]	new[55]	_	_
10-11	1295-1297	of	substance[55]	new[55]	_	_
10-12	1298-1309	mineralised	substance[55]|object[56]	new[55]|giv[56]	appos	10-15[0_56]
10-13	1310-1317	tissues	substance[55]|object[56]	new[55]|giv[56]	_	_
10-14	1318-1319	(	_	_	_	_
10-15	1320-1326	dentin	object|object[58]	giv|giv[58]	appos|coref	10-15[58_0]|11-3[62_58]
10-16	1327-1328	,	object[58]	giv[58]	_	_
10-17	1329-1335	enamel	object[58]|substance	giv[58]|new	_	_
10-18	1336-1339	and	object[58]	giv[58]	_	_
10-19	1340-1348	cementum	object[58]|substance	giv[58]|new	_	_
10-20	1349-1350	)	_	_	_	_
10-21	1351-1352	.	_	_	_	_

#Text=Breach to these tissues , as a result of dental caries , tooth fractures or cracks , can expose the dentin and provide routes for oral microbiota to ingress towards the pulp .
11-1	1353-1359	Breach	abstract[61]	new[61]	_	_
11-2	1360-1362	to	abstract[61]	new[61]	_	_
11-3	1363-1368	these	abstract[61]|object[62]	new[61]|giv[62]	coref	22-23[147_62]
11-4	1369-1376	tissues	abstract[61]|object[62]	new[61]|giv[62]	_	_
11-5	1377-1378	,	_	_	_	_
11-6	1379-1381	as	_	_	_	_
11-7	1382-1383	a	_	_	_	_
11-8	1384-1390	result	_	_	_	_
11-9	1391-1393	of	_	_	_	_
11-10	1394-1400	dental	object[63]	new[63]	coref	17-45[0_63]
11-11	1401-1407	caries	object[63]	new[63]	_	_
11-12	1408-1409	,	_	_	_	_
11-13	1410-1415	tooth	object|event[65]	new|new[65]	_	_
11-14	1416-1425	fractures	event[65]	new[65]	_	_
11-15	1426-1428	or	_	_	_	_
11-16	1429-1435	cracks	abstract	new	coref	17-15
11-17	1436-1437	,	_	_	_	_
11-18	1438-1441	can	_	_	_	_
11-19	1442-1448	expose	_	_	_	_
11-20	1449-1452	the	object[67]	new[67]	coref	25-28[0_67]
11-21	1453-1459	dentin	object[67]	new[67]	_	_
11-22	1460-1463	and	_	_	_	_
11-23	1464-1471	provide	_	_	_	_
11-24	1472-1478	routes	place[68]	new[68]	_	_
11-25	1479-1482	for	place[68]	new[68]	_	_
11-26	1483-1487	oral	place[68]|substance[69]	new[68]|new[69]	_	_
11-27	1488-1498	microbiota	place[68]|substance[69]	new[68]|new[69]	_	_
11-28	1499-1501	to	place[68]	new[68]	_	_
11-29	1502-1509	ingress	place[68]	new[68]	_	_
11-30	1510-1517	towards	place[68]	new[68]	_	_
11-31	1518-1521	the	place[68]|object[70]	new[68]|giv[70]	coref	12-4[0_70]
11-32	1522-1526	pulp	place[68]|object[70]	new[68]|giv[70]	_	_
11-33	1527-1528	.	_	_	_	_

#Text=Another route of pulp infection is the direct invasion of microorganisms to the pulp during root canal treatment during substandard clinical procedures .
12-1	1529-1536	Another	event[71]	new[71]	coref	12-7[74_71]
12-2	1537-1542	route	event[71]	new[71]	_	_
12-3	1543-1545	of	event[71]	new[71]	_	_
12-4	1546-1550	pulp	event[71]|object|event[73]	new[71]|giv|new[73]	coref	12-13[76_0]
12-5	1551-1560	infection	event[71]|event[73]	new[71]|new[73]	_	_
12-6	1561-1563	is	_	_	_	_
12-7	1564-1567	the	event[74]	giv[74]	coref	17-4[97_74]
12-8	1568-1574	direct	event[74]	giv[74]	_	_
12-9	1575-1583	invasion	event[74]	giv[74]	_	_
12-10	1584-1586	of	event[74]	giv[74]	_	_
12-11	1587-1601	microorganisms	event[74]|abstract[75]	giv[74]|new[75]	coref	22-9[0_75]
12-12	1602-1604	to	event[74]|abstract[75]	giv[74]|new[75]	_	_
12-13	1605-1608	the	event[74]|abstract[75]|object[76]	giv[74]|new[75]|giv[76]	coref	25-21[0_76]
12-14	1609-1613	pulp	event[74]|abstract[75]|object[76]	giv[74]|new[75]|giv[76]	_	_
12-15	1614-1620	during	event[74]	giv[74]	_	_
12-16	1621-1625	root	event[74]|place[77]|event[78]	giv[74]|giv[77]|new[78]	coref|coref	19-23[126_77]|21-1[136_78]
12-17	1626-1631	canal	event[74]|place[77]|event[78]	giv[74]|giv[77]|new[78]	_	_
12-18	1632-1641	treatment	event[74]|event[78]	giv[74]|new[78]	_	_
12-19	1642-1648	during	event[74]|event[78]	giv[74]|new[78]	_	_
12-20	1649-1660	substandard	event[74]|event[78]|event[79]	giv[74]|new[78]|new[79]	_	_
12-21	1661-1669	clinical	event[74]|event[78]|event[79]	giv[74]|new[78]|new[79]	_	_
12-22	1670-1680	procedures	event[74]|event[78]|event[79]	giv[74]|new[78]|new[79]	_	_
12-23	1681-1682	.	_	_	_	_

#Text=C. albicans is the most frequently isolated species in endodontic infections .
13-1	1683-1685	C.	plant[80]	giv[80]	coref	13-4[81_80]
13-2	1686-1694	albicans	plant[80]	giv[80]	_	_
13-3	1695-1697	is	_	_	_	_
13-4	1698-1701	the	plant[81]	giv[81]	coref	16-4[93_81]
13-5	1702-1706	most	plant[81]	giv[81]	_	_
13-6	1707-1717	frequently	plant[81]	giv[81]	_	_
13-7	1718-1726	isolated	plant[81]	giv[81]	_	_
13-8	1727-1734	species	plant[81]	giv[81]	_	_
13-9	1735-1737	in	plant[81]	giv[81]	_	_
13-10	1738-1748	endodontic	plant[81]|abstract[82]	giv[81]|giv[82]	coref	14-6[85_82]
13-11	1749-1759	infections	plant[81]|abstract[82]	giv[81]|giv[82]	_	_
13-12	1760-1761	.	_	_	_	_

#Text=The prevalence of yeast in persistent infections is higher than that in primary infections .
14-1	1762-1765	The	abstract[83]	new[83]	coref	15-9[90_83]
14-2	1766-1776	prevalence	abstract[83]	new[83]	_	_
14-3	1777-1779	of	abstract[83]	new[83]	_	_
14-4	1780-1785	yeast	abstract[83]|substance	new[83]|giv	coref	18-24
14-5	1786-1788	in	abstract[83]	new[83]	_	_
14-6	1789-1799	persistent	abstract[83]|abstract[85]	new[83]|giv[85]	coref	14-13[86_85]
14-7	1800-1810	infections	abstract[83]|abstract[85]	new[83]|giv[85]	_	_
14-8	1811-1813	is	_	_	_	_
14-9	1814-1820	higher	_	_	_	_
14-10	1821-1825	than	_	_	_	_
14-11	1826-1830	that	_	_	_	_
14-12	1831-1833	in	_	_	_	_
14-13	1834-1841	primary	abstract[86]	giv[86]	coref	15-16[91_86]
14-14	1842-1852	infections	abstract[86]	giv[86]	_	_
14-15	1853-1854	.	_	_	_	_

#Text=However , two recent systematic reviews found that C. albicans prevalence does vary significantly between primary and secondary endodontic infections .
15-1	1855-1862	However	_	_	_	_
15-2	1863-1864	,	_	_	_	_
15-3	1865-1868	two	abstract[87]	new[87]	_	_
15-4	1869-1875	recent	abstract[87]	new[87]	_	_
15-5	1876-1886	systematic	abstract[87]	new[87]	_	_
15-6	1887-1894	reviews	abstract[87]	new[87]	_	_
15-7	1895-1900	found	_	_	_	_
15-8	1901-1905	that	_	_	_	_
15-9	1906-1908	C.	person|abstract[90]	new|giv[90]	coref	29-32
15-10	1909-1917	albicans	person|abstract[90]	new|giv[90]	_	_
15-11	1918-1928	prevalence	abstract[90]	giv[90]	_	_
15-12	1929-1933	does	_	_	_	_
15-13	1934-1938	vary	_	_	_	_
15-14	1939-1952	significantly	_	_	_	_
15-15	1953-1960	between	_	_	_	_
15-16	1961-1968	primary	abstract[91]	giv[91]	coref	21-13[140_91]
15-17	1969-1972	and	abstract[91]	giv[91]	_	_
15-18	1973-1982	secondary	abstract[91]	giv[91]	_	_
15-19	1983-1993	endodontic	abstract[91]	giv[91]	_	_
15-20	1994-2004	infections	abstract[91]	giv[91]	_	_
15-21	2005-2006	.	_	_	_	_

#Text=In this environment C. albicans can colonise dentinal walls and penetrate into dentinal tubules .
16-1	2007-2009	In	_	_	_	_
16-2	2010-2014	this	place[92]	new[92]	_	_
16-3	2015-2026	environment	place[92]	new[92]	_	_
16-4	2027-2029	C.	plant[93]	giv[93]	coref	26-28[182_93]
16-5	2030-2038	albicans	plant[93]	giv[93]	_	_
16-6	2039-2042	can	_	_	_	_
16-7	2043-2051	colonise	_	_	_	_
16-8	2052-2060	dentinal	object[94]	new[94]	coref	23-18[155_94]
16-9	2061-2066	walls	object[94]	new[94]	_	_
16-10	2067-2070	and	_	_	_	_
16-11	2071-2080	penetrate	_	_	_	_
16-12	2081-2085	into	_	_	_	_
16-13	2086-2094	dentinal	substance[95]	new[95]	coref	17-40
16-14	2095-2102	tubules	substance[95]	new[95]	_	_
16-15	2103-2104	.	_	_	_	_

#Text=The route of fungal invasion to the root canals is likely to be through cracks or via leaking restoration , though the diameter of hyphae , which is 1.9 – 2.6 µm , cannot exclude the possibility of dentinal tubules invasion especially in deep caries lesions .
17-1	2105-2108	The	abstract[96]	new[96]	_	_
17-2	2109-2114	route	abstract[96]	new[96]	_	_
17-3	2115-2117	of	abstract[96]	new[96]	_	_
17-4	2118-2124	fungal	abstract[96]|event[97]	new[96]|giv[97]	coref	17-39[106_97]
17-5	2125-2133	invasion	abstract[96]|event[97]	new[96]|giv[97]	_	_
17-6	2134-2136	to	abstract[96]|event[97]	new[96]|giv[97]	_	_
17-7	2137-2140	the	abstract[96]|event[97]|place[98]	new[96]|giv[97]|new[98]	coref	20-19[132_98]
17-8	2141-2145	root	abstract[96]|event[97]|place[98]	new[96]|giv[97]|new[98]	_	_
17-9	2146-2152	canals	abstract[96]|event[97]|place[98]	new[96]|giv[97]|new[98]	_	_
17-10	2153-2155	is	_	_	_	_
17-11	2156-2162	likely	_	_	_	_
17-12	2163-2165	to	_	_	_	_
17-13	2166-2168	be	_	_	_	_
17-14	2169-2176	through	_	_	_	_
17-15	2177-2183	cracks	abstract	giv	_	_
17-16	2184-2186	or	_	_	_	_
17-17	2187-2190	via	_	_	_	_
17-18	2191-2198	leaking	event[100]	new[100]	_	_
17-19	2199-2210	restoration	event[100]	new[100]	_	_
17-20	2211-2212	,	_	_	_	_
17-21	2213-2219	though	_	_	_	_
17-22	2220-2223	the	abstract[101]	new[101]	_	_
17-23	2224-2232	diameter	abstract[101]	new[101]	_	_
17-24	2233-2235	of	abstract[101]	new[101]	_	_
17-25	2236-2242	hyphae	abstract[101]|substance	new[101]|new	_	_
17-26	2243-2244	,	abstract[101]	new[101]	_	_
17-27	2245-2250	which	abstract[101]|person[103]	new[101]|new[103]	_	_
17-28	2251-2253	is	abstract[101]|person[103]	new[101]|new[103]	_	_
17-29	2254-2257	1.9	abstract[101]|person[103]	new[101]|new[103]	_	_
17-30	2258-2259	–	abstract[101]|person[103]	new[101]|new[103]	_	_
17-31	2260-2263	2.6	abstract[101]|person[103]	new[101]|new[103]	_	_
17-32	2264-2266	µm	abstract[101]|person[103]	new[101]|new[103]	_	_
17-33	2267-2268	,	_	_	_	_
17-34	2269-2275	cannot	_	_	_	_
17-35	2276-2283	exclude	_	_	_	_
17-36	2284-2287	the	abstract[104]	new[104]	_	_
17-37	2288-2299	possibility	abstract[104]	new[104]	_	_
17-38	2300-2302	of	abstract[104]	new[104]	_	_
17-39	2303-2311	dentinal	abstract[104]|event[106]	new[104]|giv[106]	_	_
17-40	2312-2319	tubules	abstract[104]|substance|event[106]	new[104]|giv|giv[106]	_	_
17-41	2320-2328	invasion	abstract[104]|event[106]	new[104]|giv[106]	_	_
17-42	2329-2339	especially	object[108]	new[108]	_	_
17-43	2340-2342	in	object[108]	new[108]	_	_
17-44	2343-2347	deep	object[108]	new[108]	_	_
17-45	2348-2354	caries	object|object[108]	giv|new[108]	_	_
17-46	2355-2362	lesions	object[108]	new[108]	_	_
17-47	2363-2364	.	_	_	_	_

#Text=Here , candida yeasts are capable of coalescing with one another in the form of biofilm , which is a multicellular community of yeast and hyphal forms encased in polymeric glue .
18-1	2365-2369	Here	_	_	_	_
18-2	2370-2371	,	_	_	_	_
18-3	2372-2379	candida	substance|plant[110]	new|giv[110]	_	_
18-4	2380-2386	yeasts	plant[110]	giv[110]	_	_
18-5	2387-2390	are	_	_	_	_
18-6	2391-2398	capable	_	_	_	_
18-7	2399-2401	of	_	_	_	_
18-8	2402-2412	coalescing	_	_	_	_
18-9	2413-2417	with	_	_	_	_
18-10	2418-2421	one	object[111]	new[111]	_	_
18-11	2422-2429	another	object[111]	new[111]	_	_
18-12	2430-2432	in	_	_	_	_
18-13	2433-2436	the	abstract[112]	new[112]	_	_
18-14	2437-2441	form	abstract[112]	new[112]	_	_
18-15	2442-2444	of	abstract[112]	new[112]	_	_
18-16	2445-2452	biofilm	abstract[112]|object[113]	new[112]|giv[113]	coref	19-2[0_113]
18-17	2453-2454	,	abstract[112]|object[113]	new[112]|giv[113]	_	_
18-18	2455-2460	which	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-19	2461-2463	is	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-20	2464-2465	a	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-21	2466-2479	multicellular	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-22	2480-2489	community	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-23	2490-2492	of	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-24	2493-2498	yeast	abstract[112]|object[113]|abstract[114]|substance	new[112]|giv[113]|new[114]|giv	coref	29-29[208_0]
18-25	2499-2502	and	abstract[112]|object[113]|abstract[114]	new[112]|giv[113]|new[114]	_	_
18-26	2503-2509	hyphal	abstract[112]|object[113]|abstract[114]|abstract[116]	new[112]|giv[113]|new[114]|new[116]	_	_
18-27	2510-2515	forms	abstract[112]|object[113]|abstract[114]|abstract[116]	new[112]|giv[113]|new[114]|new[116]	_	_
18-28	2516-2523	encased	abstract[112]|object[113]|abstract[114]|abstract[116]	new[112]|giv[113]|new[114]|new[116]	_	_
18-29	2524-2526	in	abstract[112]|object[113]|abstract[114]|abstract[116]	new[112]|giv[113]|new[114]|new[116]	_	_
18-30	2527-2536	polymeric	abstract[112]|object[113]|abstract[114]|abstract[116]|substance[117]	new[112]|giv[113]|new[114]|new[116]|new[117]	_	_
18-31	2537-2541	glue	abstract[112]|object[113]|abstract[114]|abstract[116]|substance[117]	new[112]|giv[113]|new[114]|new[116]|new[117]	_	_
18-32	2542-2543	.	_	_	_	_

#Text=The biofilm lifestyle enhances the ability of the cells to withstand host and antifungal factors , ultimately contributing to its persistence within the root canal .
19-1	2544-2547	The	abstract[119]	new[119]	_	_
19-2	2548-2555	biofilm	object|abstract[119]	giv|new[119]	coref	23-15[153_0]
19-3	2556-2565	lifestyle	abstract[119]	new[119]	_	_
19-4	2566-2574	enhances	_	_	_	_
19-5	2575-2578	the	abstract[120]	giv[120]	ana	19-20[0_120]
19-6	2579-2586	ability	abstract[120]	giv[120]	_	_
19-7	2587-2589	of	abstract[120]	giv[120]	_	_
19-8	2590-2593	the	abstract[120]|object[121]	giv[120]|giv[121]	_	_
19-9	2594-2599	cells	abstract[120]|object[121]	giv[120]|giv[121]	_	_
19-10	2600-2602	to	abstract[120]|object[121]	giv[120]|giv[121]	_	_
19-11	2603-2612	withstand	abstract[120]|object[121]	giv[120]|giv[121]	_	_
19-12	2613-2617	host	abstract[120]|object[121]|animal|abstract[123]	giv[120]|giv[121]|giv|new[123]	_	_
19-13	2618-2621	and	abstract[120]|object[121]|abstract[123]	giv[120]|giv[121]|new[123]	_	_
19-14	2622-2632	antifungal	abstract[120]|object[121]|abstract[123]	giv[120]|giv[121]|new[123]	_	_
19-15	2633-2640	factors	abstract[120]|object[121]|abstract[123]	giv[120]|giv[121]|new[123]	_	_
19-16	2641-2642	,	_	_	_	_
19-17	2643-2653	ultimately	_	_	_	_
19-18	2654-2666	contributing	_	_	_	_
19-19	2667-2669	to	_	_	_	_
19-20	2670-2673	its	abstract|abstract[125]	giv|new[125]	coref	32-5[237_0]
19-21	2674-2685	persistence	abstract[125]	new[125]	_	_
19-22	2686-2692	within	abstract[125]	new[125]	_	_
19-23	2693-2696	the	abstract[125]|place[126]	new[125]|giv[126]	coref	20-9[129_126]
19-24	2697-2701	root	abstract[125]|place[126]	new[125]|giv[126]	_	_
19-25	2702-2707	canal	abstract[125]|place[126]	new[125]|giv[126]	_	_
19-26	2708-2709	.	_	_	_	_

#Text=This phenotype , along with the complexity of root canal system , particularly in the apical third of root canals , are thought to be the major causes of treatment-resistant apical periodontitis .
20-1	2710-2714	This	abstract[127]	new[127]	_	_
20-2	2715-2724	phenotype	abstract[127]	new[127]	_	_
20-3	2725-2726	,	_	_	_	_
20-4	2727-2732	along	_	_	_	_
20-5	2733-2737	with	_	_	_	_
20-6	2738-2741	the	abstract[128]	new[128]	_	_
20-7	2742-2752	complexity	abstract[128]	new[128]	_	_
20-8	2753-2755	of	abstract[128]	new[128]	_	_
20-9	2756-2760	root	abstract[128]|place[129]|abstract[130]	new[128]|giv[129]|new[130]	coref|coref	21-1[135_129]|22-11[144_130]
20-10	2761-2766	canal	abstract[128]|place[129]|abstract[130]	new[128]|giv[129]|new[130]	_	_
20-11	2767-2773	system	abstract[128]|abstract[130]	new[128]|new[130]	_	_
20-12	2774-2775	,	_	_	_	_
20-13	2776-2788	particularly	abstract[131]	new[131]	_	_
20-14	2789-2791	in	abstract[131]	new[131]	_	_
20-15	2792-2795	the	abstract[131]	new[131]	_	_
20-16	2796-2802	apical	abstract[131]	new[131]	_	_
20-17	2803-2808	third	abstract[131]	new[131]	_	_
20-18	2809-2811	of	abstract[131]	new[131]	_	_
20-19	2812-2816	root	abstract[131]|place[132]	new[131]|giv[132]	coref	24-25[162_132]
20-20	2817-2823	canals	abstract[131]|place[132]	new[131]|giv[132]	_	_
20-21	2824-2825	,	_	_	_	_
20-22	2826-2829	are	_	_	_	_
20-23	2830-2837	thought	_	_	_	_
20-24	2838-2840	to	_	_	_	_
20-25	2841-2843	be	_	_	_	_
20-26	2844-2847	the	abstract[133]	new[133]	_	_
20-27	2848-2853	major	abstract[133]	new[133]	_	_
20-28	2854-2860	causes	abstract[133]	new[133]	_	_
20-29	2861-2863	of	abstract[133]	new[133]	_	_
20-30	2864-2883	treatment-resistant	abstract[133]|abstract[134]	new[133]|giv[134]	_	_
20-31	2884-2890	apical	abstract[133]|abstract[134]	new[133]|giv[134]	_	_
20-32	2891-2904	periodontitis	abstract[133]|abstract[134]	new[133]|giv[134]	_	_
20-33	2905-2906	.	_	_	_	_

#Text=Root canal treatment ( RCT ) is the treatment of choice for these endodontic infections .
21-1	2907-2911	Root	place[135]|event[136]	giv[135]|giv[136]	coref|coref	21-8[138_136]|22-12[143_135]
21-2	2912-2917	canal	place[135]|event[136]	giv[135]|giv[136]	_	_
21-3	2918-2927	treatment	event[136]	giv[136]	_	_
21-4	2928-2929	(	_	_	_	_
21-5	2930-2933	RCT	abstract	new	coref	22-1
21-6	2934-2935	)	_	_	_	_
21-7	2936-2938	is	_	_	_	_
21-8	2939-2942	the	event[138]	giv[138]	coref	31-39[0_138]
21-9	2943-2952	treatment	event[138]	giv[138]	_	_
21-10	2953-2955	of	event[138]	giv[138]	_	_
21-11	2956-2962	choice	event[138]|abstract	giv[138]|new	_	_
21-12	2963-2966	for	event[138]	giv[138]	_	_
21-13	2967-2972	these	event[138]|abstract[140]	giv[138]|giv[140]	coref	34-17[260_140]
21-14	2973-2983	endodontic	event[138]|abstract[140]	giv[138]|giv[140]	_	_
21-15	2984-2994	infections	event[138]|abstract[140]	giv[138]|giv[140]	_	_
21-16	2995-2996	.	_	_	_	_

#Text=RCT aims to : ( 1 ) eliminate microorganisms from the root canal system to a level that promotes the healing of periradicular tissues , and ( 2 ) provide a three-dimensional hermetic seal to prevent reinfection .
22-1	2997-3000	RCT	abstract	giv	coref	23-9
22-2	3001-3005	aims	_	_	_	_
22-3	3006-3008	to	_	_	_	_
22-4	3009-3010	:	_	_	_	_
22-5	3011-3012	(	_	_	_	_
22-6	3013-3014	1	_	_	_	_
22-7	3015-3016	)	_	_	_	_
22-8	3017-3026	eliminate	_	_	_	_
22-9	3027-3041	microorganisms	abstract	giv	coref	26-24[181_0]
22-10	3042-3046	from	_	_	_	_
22-11	3047-3050	the	abstract[144]	giv[144]	_	_
22-12	3051-3055	root	place[143]|abstract[144]	giv[143]|giv[144]	coref	23-19[154_143]
22-13	3056-3061	canal	place[143]|abstract[144]	giv[143]|giv[144]	_	_
22-14	3062-3068	system	abstract[144]	giv[144]	_	_
22-15	3069-3071	to	_	_	_	_
22-16	3072-3073	a	abstract[145]	new[145]	_	_
22-17	3074-3079	level	abstract[145]	new[145]	_	_
22-18	3080-3084	that	abstract[145]	new[145]	_	_
22-19	3085-3093	promotes	abstract[145]	new[145]	_	_
22-20	3094-3097	the	abstract[145]|event[146]	new[145]|new[146]	_	_
22-21	3098-3105	healing	abstract[145]|event[146]	new[145]|new[146]	_	_
22-22	3106-3108	of	abstract[145]|event[146]	new[145]|new[146]	_	_
22-23	3109-3122	periradicular	abstract[145]|event[146]|object[147]	new[145]|new[146]|giv[147]	coref	25-19[173_147]
22-24	3123-3130	tissues	abstract[145]|event[146]|object[147]	new[145]|new[146]|giv[147]	_	_
22-25	3131-3132	,	_	_	_	_
22-26	3133-3136	and	_	_	_	_
22-27	3137-3138	(	_	_	_	_
22-28	3139-3140	2	_	_	_	_
22-29	3141-3142	)	_	_	_	_
22-30	3143-3150	provide	_	_	_	_
22-31	3151-3152	a	object[148]	new[148]	_	_
22-32	3153-3170	three-dimensional	object[148]	new[148]	_	_
22-33	3171-3179	hermetic	object[148]	new[148]	_	_
22-34	3180-3184	seal	object[148]	new[148]	_	_
22-35	3185-3187	to	_	_	_	_
22-36	3188-3195	prevent	_	_	_	_
22-37	3196-3207	reinfection	event	new	_	_
22-38	3208-3209	.	_	_	_	_

#Text=Different hand and rotary instruments are used during RCT in order to mechanically debride the biofilm on the root canal walls .
23-1	3210-3219	Different	object[150]|object[151]	new[150]|new[151]	coref	24-17[160_151]
23-2	3220-3224	hand	object[150]|object[151]	new[150]|new[151]	_	_
23-3	3225-3228	and	object[151]	new[151]	_	_
23-4	3229-3235	rotary	object[151]	new[151]	_	_
23-5	3236-3247	instruments	object[151]	new[151]	_	_
23-6	3248-3251	are	_	_	_	_
23-7	3252-3256	used	_	_	_	_
23-8	3257-3263	during	_	_	_	_
23-9	3264-3267	RCT	abstract	giv	coref	28-23[194_0]
23-10	3268-3270	in	_	_	_	_
23-11	3271-3276	order	_	_	_	_
23-12	3277-3279	to	_	_	_	_
23-13	3280-3292	mechanically	_	_	_	_
23-14	3293-3300	debride	_	_	_	_
23-15	3301-3304	the	object[153]	giv[153]	coref	29-42[0_153]
23-16	3305-3312	biofilm	object[153]	giv[153]	_	_
23-17	3313-3315	on	_	_	_	_
23-18	3316-3319	the	object[155]	giv[155]	coref	25-11[167_155]
23-19	3320-3324	root	place[154]|object[155]	giv[154]|giv[155]	coref	24-5[156_154]
23-20	3325-3330	canal	place[154]|object[155]	giv[154]|giv[155]	_	_
23-21	3331-3336	walls	object[155]	giv[155]	_	_
23-22	3337-3338	.	_	_	_	_

#Text=Nevertheless , the cross-sectional root canal configuration can pose a challenge to adequate debridement , as these instruments tend to leave untouched recesses in oval canals .
24-1	3339-3351	Nevertheless	_	_	_	_
24-2	3352-3353	,	_	_	_	_
24-3	3354-3357	the	abstract[157]	new[157]	_	_
24-4	3358-3373	cross-sectional	abstract[157]	new[157]	_	_
24-5	3374-3378	root	place[156]|abstract[157]	giv[156]|new[157]	coref	25-12[166_156]
24-6	3379-3384	canal	place[156]|abstract[157]	giv[156]|new[157]	_	_
24-7	3385-3398	configuration	abstract[157]	new[157]	_	_
24-8	3399-3402	can	_	_	_	_
24-9	3403-3407	pose	_	_	_	_
24-10	3408-3409	a	abstract[158]	new[158]	_	_
24-11	3410-3419	challenge	abstract[158]	new[158]	_	_
24-12	3420-3422	to	abstract[158]	new[158]	_	_
24-13	3423-3431	adequate	abstract[158]|abstract[159]	new[158]|new[159]	coref	28-11[190_159]
24-14	3432-3443	debridement	abstract[158]|abstract[159]	new[158]|new[159]	_	_
24-15	3444-3445	,	_	_	_	_
24-16	3446-3448	as	_	_	_	_
24-17	3449-3454	these	object[160]	giv[160]	_	_
24-18	3455-3466	instruments	object[160]	giv[160]	_	_
24-19	3467-3471	tend	_	_	_	_
24-20	3472-3474	to	_	_	_	_
24-21	3475-3480	leave	_	_	_	_
24-22	3481-3490	untouched	abstract[161]	new[161]	_	_
24-23	3491-3499	recesses	abstract[161]	new[161]	_	_
24-24	3500-3502	in	abstract[161]	new[161]	_	_
24-25	3503-3507	oval	abstract[161]|place[162]	new[161]|giv[162]	coref	34-47[271_162]
24-26	3508-3514	canals	abstract[161]|place[162]	new[161]|giv[162]	_	_
24-27	3515-3516	.	_	_	_	_

#Text=This instrumentation can however create a smear layer that covers the root canal walls , which consists of organic ( pulp tissue remnants ) and inorganic ( dentin chips ) tissues .
25-1	3517-3521	This	abstract[163]	new[163]	_	_
25-2	3522-3537	instrumentation	abstract[163]	new[163]	_	_
25-3	3538-3541	can	_	_	_	_
25-4	3542-3549	however	_	_	_	_
25-5	3550-3556	create	_	_	_	_
25-6	3557-3558	a	abstract[165]	new[165]	coref	26-1[174_165]
25-7	3559-3564	smear	substance|abstract[165]	new|new[165]	coref	28-18
25-8	3565-3570	layer	abstract[165]	new[165]	_	_
25-9	3571-3575	that	abstract[165]	new[165]	_	_
25-10	3576-3582	covers	abstract[165]	new[165]	_	_
25-11	3583-3586	the	abstract[165]|object[167]	new[165]|giv[167]	coref	26-14[179_167]
25-12	3587-3591	root	abstract[165]|place[166]|object[167]	new[165]|giv[166]|giv[167]	coref	26-15[0_166]
25-13	3592-3597	canal	abstract[165]|place[166]|object[167]	new[165]|giv[166]|giv[167]	_	_
25-14	3598-3603	walls	abstract[165]|object[167]	new[165]|giv[167]	_	_
25-15	3604-3605	,	abstract[165]|object[167]	new[165]|giv[167]	_	_
25-16	3606-3611	which	abstract[165]|object[167]	new[165]|giv[167]	_	_
25-17	3612-3620	consists	abstract[165]|object[167]	new[165]|giv[167]	_	_
25-18	3621-3623	of	abstract[165]|object[167]	new[165]|giv[167]	_	_
25-19	3624-3631	organic	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-20	3632-3633	(	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-21	3634-3638	pulp	abstract[165]|object[167]|object|object[169]|object[170]|object[173]	new[165]|giv[167]|giv|giv[169]|new[170]|giv[173]	coref|appos	25-21[169_0]|25-28[172_170]
25-22	3639-3645	tissue	abstract[165]|object[167]|object[169]|object[170]|object[173]	new[165]|giv[167]|giv[169]|new[170]|giv[173]	_	_
25-23	3646-3654	remnants	abstract[165]|object[167]|object[170]|object[173]	new[165]|giv[167]|new[170]|giv[173]	_	_
25-24	3655-3656	)	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-25	3657-3660	and	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-26	3661-3670	inorganic	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-27	3671-3672	(	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-28	3673-3679	dentin	abstract[165]|object[167]|object|object[172]|object[173]	new[165]|giv[167]|giv|giv[172]|giv[173]	_	_
25-29	3680-3685	chips	abstract[165]|object[167]|object[172]|object[173]	new[165]|giv[167]|giv[172]|giv[173]	_	_
25-30	3686-3687	)	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-31	3688-3695	tissues	abstract[165]|object[167]|object[173]	new[165]|giv[167]|giv[173]	_	_
25-32	3696-3697	.	_	_	_	_

#Text=This layer might act as a protective barrier to encase biofilms formed on root canal walls and might also encourage the adherence of microorganisms , such as C. albicans .
26-1	3698-3702	This	abstract[174]	giv[174]	coref	28-17[193_174]
26-2	3703-3708	layer	abstract[174]	giv[174]	_	_
26-3	3709-3714	might	_	_	_	_
26-4	3715-3718	act	_	_	_	_
26-5	3719-3721	as	_	_	_	_
26-6	3722-3723	a	object[175]	new[175]	_	_
26-7	3724-3734	protective	object[175]	new[175]	_	_
26-8	3735-3742	barrier	object[175]	new[175]	_	_
26-9	3743-3745	to	object[175]	new[175]	_	_
26-10	3746-3752	encase	object[175]	new[175]	_	_
26-11	3753-3761	biofilms	object[175]|substance[176]	new[175]|new[176]	_	_
26-12	3762-3768	formed	object[175]|substance[176]	new[175]|new[176]	_	_
26-13	3769-3771	on	object[175]|substance[176]	new[175]|new[176]	_	_
26-14	3772-3776	root	object[175]|substance[176]|object|object[179]	new[175]|new[176]|new|giv[179]	_	_
26-15	3777-3782	canal	object[175]|substance[176]|place|object[179]	new[175]|new[176]|giv|giv[179]	coref	27-9[185_0]
26-16	3783-3788	walls	object[175]|substance[176]|object[179]	new[175]|new[176]|giv[179]	_	_
26-17	3789-3792	and	_	_	_	_
26-18	3793-3798	might	_	_	_	_
26-19	3799-3803	also	_	_	_	_
26-20	3804-3813	encourage	_	_	_	_
26-21	3814-3817	the	abstract[180]	new[180]	ana	27-3[0_180]
26-22	3818-3827	adherence	abstract[180]	new[180]	_	_
26-23	3828-3830	of	abstract[180]	new[180]	_	_
26-24	3831-3845	microorganisms	abstract[180]|abstract[181]	new[180]|giv[181]	coref	31-15[0_181]
26-25	3846-3847	,	abstract[180]|abstract[181]	new[180]|giv[181]	_	_
26-26	3848-3852	such	abstract[180]|abstract[181]	new[180]|giv[181]	_	_
26-27	3853-3855	as	abstract[180]|abstract[181]	new[180]|giv[181]	_	_
26-28	3856-3858	C.	abstract[180]|abstract[181]|plant[182]	new[180]|giv[181]|giv[182]	coref	29-32[210_182]
26-29	3859-3867	albicans	abstract[180]|abstract[181]|plant[182]	new[180]|giv[181]|giv[182]	_	_
26-30	3868-3869	.	_	_	_	_

#Text=Furthermore , it may compromise the quality of root canal sealing .
27-1	3870-3881	Furthermore	_	_	_	_
27-2	3882-3883	,	_	_	_	_
27-3	3884-3886	it	abstract	giv	_	_
27-4	3887-3890	may	_	_	_	_
27-5	3891-3901	compromise	_	_	_	_
27-6	3902-3905	the	abstract[184]	new[184]	_	_
27-7	3906-3913	quality	abstract[184]	new[184]	_	_
27-8	3914-3916	of	abstract[184]	new[184]	_	_
27-9	3917-3921	root	abstract[184]|place[185]|abstract[186]	new[184]|giv[185]|new[186]	coref	28-11[189_185]
27-10	3922-3927	canal	abstract[184]|place[185]|abstract[186]	new[184]|giv[185]|new[186]	_	_
27-11	3928-3935	sealing	abstract[184]|abstract[186]	new[184]|new[186]	_	_
27-12	3936-3937	.	_	_	_	_

#Text=Therefore , the use of chemical irrigating solutions to maximise root canal debridement and removal of the smear layer is vital for successful RCT , which includes ethylenediaminetetraacetic acid ( EDTA ) , though not universally .
28-1	3938-3947	Therefore	_	_	_	_
28-2	3948-3949	,	_	_	_	_
28-3	3950-3953	the	event[187]	new[187]	_	_
28-4	3954-3957	use	event[187]	new[187]	_	_
28-5	3958-3960	of	event[187]	new[187]	_	_
28-6	3961-3969	chemical	event[187]|substance[188]	new[187]|new[188]	_	_
28-7	3970-3980	irrigating	event[187]|substance[188]	new[187]|new[188]	_	_
28-8	3981-3990	solutions	event[187]|substance[188]	new[187]|new[188]	_	_
28-9	3991-3993	to	event[187]|substance[188]	new[187]|new[188]	_	_
28-10	3994-4002	maximise	event[187]|substance[188]	new[187]|new[188]	_	_
28-11	4003-4007	root	event[187]|substance[188]|place[189]|abstract[190]	new[187]|new[188]|giv[189]|giv[190]	coref	34-23[262_189]
28-12	4008-4013	canal	event[187]|substance[188]|place[189]|abstract[190]	new[187]|new[188]|giv[189]|giv[190]	_	_
28-13	4014-4025	debridement	event[187]|substance[188]|abstract[190]	new[187]|new[188]|giv[190]	_	_
28-14	4026-4029	and	event[187]|substance[188]	new[187]|new[188]	_	_
28-15	4030-4037	removal	event[187]|substance[188]|event[191]	new[187]|new[188]|new[191]	_	_
28-16	4038-4040	of	event[187]|substance[188]|event[191]	new[187]|new[188]|new[191]	_	_
28-17	4041-4044	the	event[187]|substance[188]|event[191]|abstract[193]	new[187]|new[188]|new[191]|giv[193]	coref	29-10[202_193]
28-18	4045-4050	smear	event[187]|substance[188]|event[191]|substance|abstract[193]	new[187]|new[188]|new[191]|giv|giv[193]	coref	29-10
28-19	4051-4056	layer	event[187]|substance[188]|event[191]|abstract[193]	new[187]|new[188]|new[191]|giv[193]	_	_
28-20	4057-4059	is	_	_	_	_
28-21	4060-4065	vital	_	_	_	_
28-22	4066-4069	for	_	_	_	_
28-23	4070-4080	successful	abstract[194]	giv[194]	_	_
28-24	4081-4084	RCT	abstract[194]	giv[194]	_	_
28-25	4085-4086	,	abstract[194]	giv[194]	_	_
28-26	4087-4092	which	abstract[194]	giv[194]	_	_
28-27	4093-4101	includes	abstract[194]	giv[194]	_	_
28-28	4102-4128	ethylenediaminetetraacetic	abstract[194]|abstract|substance[196]	giv[194]|new|new[196]	_	_
28-29	4129-4133	acid	abstract[194]|substance[196]	giv[194]|new[196]	_	_
28-30	4134-4135	(	_	_	_	_
28-31	4136-4140	EDTA	abstract	new	coref	29-1
28-32	4141-4142	)	_	_	_	_
28-33	4143-4144	,	_	_	_	_
28-34	4145-4151	though	_	_	_	_
28-35	4152-4155	not	_	_	_	_
28-36	4156-4167	universally	_	_	_	_
28-37	4168-4169	.	_	_	_	_

#Text=EDTA acts mainly as an adjunct irrigant to remove smear layer , though an alternative effect is the inhibition of filamentation through chelation of necessary divalent cations in the pathogenic yeast C. albicans , a structural element strongly associated with robust biofilm formation .
29-1	4170-4174	EDTA	abstract	giv	coref	34-9
29-2	4175-4179	acts	_	_	_	_
29-3	4180-4186	mainly	_	_	_	_
29-4	4187-4189	as	_	_	_	_
29-5	4190-4192	an	abstract[200]	new[200]	_	_
29-6	4193-4200	adjunct	abstract|abstract[200]	new|new[200]	_	_
29-7	4201-4209	irrigant	abstract[200]	new[200]	_	_
29-8	4210-4212	to	_	_	_	_
29-9	4213-4219	remove	_	_	_	_
29-10	4220-4225	smear	substance|abstract[202]	giv|giv[202]	_	_
29-11	4226-4231	layer	abstract[202]	giv[202]	_	_
29-12	4232-4233	,	_	_	_	_
29-13	4234-4240	though	_	_	_	_
29-14	4241-4243	an	event[203]	new[203]	coref	29-18[204_203]
29-15	4244-4255	alternative	event[203]	new[203]	_	_
29-16	4256-4262	effect	event[203]	new[203]	_	_
29-17	4263-4265	is	_	_	_	_
29-18	4266-4269	the	event[204]	giv[204]	_	_
29-19	4270-4280	inhibition	event[204]	giv[204]	_	_
29-20	4281-4283	of	event[204]	giv[204]	_	_
29-21	4284-4297	filamentation	event[204]|abstract	giv[204]|new	_	_
29-22	4298-4305	through	event[204]	giv[204]	_	_
29-23	4306-4315	chelation	event[204]|abstract[206]	giv[204]|new[206]	_	_
29-24	4316-4318	of	event[204]|abstract[206]	giv[204]|new[206]	_	_
29-25	4319-4328	necessary	event[204]|abstract[206]|substance[207]	giv[204]|new[206]|new[207]	_	_
29-26	4329-4337	divalent	event[204]|abstract[206]|substance[207]	giv[204]|new[206]|new[207]	_	_
29-27	4338-4345	cations	event[204]|abstract[206]|substance[207]	giv[204]|new[206]|new[207]	_	_
29-28	4346-4348	in	event[204]|abstract[206]|substance[207]	giv[204]|new[206]|new[207]	_	_
29-29	4349-4352	the	event[204]|abstract[206]|substance[207]|substance[208]	giv[204]|new[206]|new[207]|giv[208]	coref	33-4[243_208]
29-30	4353-4363	pathogenic	event[204]|abstract[206]|substance[207]|substance[208]	giv[204]|new[206]|new[207]|giv[208]	_	_
29-31	4364-4369	yeast	event[204]|abstract[206]|substance[207]|substance[208]	giv[204]|new[206]|new[207]|giv[208]	_	_
29-32	4370-4372	C.	person|plant[210]	giv|giv[210]	coref|coref	30-17|30-17[222_210]
29-33	4373-4381	albicans	plant[210]	giv[210]	_	_
29-34	4382-4383	,	_	_	_	_
29-35	4384-4385	a	substance[211]	new[211]	_	_
29-36	4386-4396	structural	substance[211]	new[211]	_	_
29-37	4397-4404	element	substance[211]	new[211]	_	_
29-38	4405-4413	strongly	substance[211]	new[211]	_	_
29-39	4414-4424	associated	substance[211]	new[211]	_	_
29-40	4425-4429	with	substance[211]	new[211]	_	_
29-41	4430-4436	robust	substance[211]|event[213]	new[211]|new[213]	_	_
29-42	4437-4444	biofilm	substance[211]|object|event[213]	new[211]|giv|new[213]	coref	30-12
29-43	4445-4454	formation	substance[211]|event[213]	new[211]|new[213]	_	_
29-44	4455-4456	.	_	_	_	_

#Text=Recent work from our group has highlighted the clinical relevance of biofilm heterogeneity between isolates of C. albicans from the oral cavity and other clinical sites .
30-1	4457-4463	Recent	abstract[214]	new[214]	_	_
30-2	4464-4468	work	abstract[214]	new[214]	_	_
30-3	4469-4473	from	abstract[214]	new[214]	_	_
30-4	4474-4477	our	abstract[214]|person|person[216]	new[214]|acc|new[216]	ana	32-1
30-5	4478-4483	group	abstract[214]|person[216]	new[214]|new[216]	_	_
30-6	4484-4487	has	_	_	_	_
30-7	4488-4499	highlighted	_	_	_	_
30-8	4500-4503	the	abstract[217]	new[217]	_	_
30-9	4504-4512	clinical	abstract[217]	new[217]	_	_
30-10	4513-4522	relevance	abstract[217]	new[217]	_	_
30-11	4523-4525	of	abstract[217]	new[217]	_	_
30-12	4526-4533	biofilm	abstract[217]|object|abstract[219]	new[217]|giv|new[219]	coref|coref	32-10|34-34[268_219]
30-13	4534-4547	heterogeneity	abstract[217]|abstract[219]	new[217]|new[219]	_	_
30-14	4548-4555	between	abstract[217]|abstract[219]	new[217]|new[219]	_	_
30-15	4556-4564	isolates	abstract[217]|abstract[219]|substance[220]	new[217]|new[219]|new[220]	_	_
30-16	4565-4567	of	abstract[217]|abstract[219]|substance[220]	new[217]|new[219]|new[220]	_	_
30-17	4568-4570	C.	abstract[217]|abstract[219]|substance[220]|person|plant[222]	new[217]|new[219]|new[220]|giv|giv[222]	coref|coref	33-12|34-28[266_222]
30-18	4571-4579	albicans	abstract[217]|abstract[219]|substance[220]|plant[222]	new[217]|new[219]|new[220]|giv[222]	_	_
30-19	4580-4584	from	abstract[217]|abstract[219]|substance[220]|plant[222]	new[217]|new[219]|new[220]|giv[222]	_	_
30-20	4585-4588	the	abstract[217]|abstract[219]|substance[220]|plant[222]|place[223]	new[217]|new[219]|new[220]|giv[222]|new[223]	ana	31-33[0_223]
30-21	4589-4593	oral	abstract[217]|abstract[219]|substance[220]|plant[222]|place[223]	new[217]|new[219]|new[220]|giv[222]|new[223]	_	_
30-22	4594-4600	cavity	abstract[217]|abstract[219]|substance[220]|plant[222]|place[223]	new[217]|new[219]|new[220]|giv[222]|new[223]	_	_
30-23	4601-4604	and	abstract[217]|abstract[219]|substance[220]|plant[222]	new[217]|new[219]|new[220]|giv[222]	_	_
30-24	4605-4610	other	abstract[217]|abstract[219]|substance[220]|plant[222]|place[224]	new[217]|new[219]|new[220]|giv[222]|new[224]	ana	31-17[0_224]
30-25	4611-4619	clinical	abstract[217]|abstract[219]|substance[220]|plant[222]|place[224]	new[217]|new[219]|new[220]|giv[222]|new[224]	_	_
30-26	4620-4625	sites	abstract[217]|abstract[219]|substance[220]|plant[222]|place[224]	new[217]|new[219]|new[220]|giv[222]|new[224]	_	_
30-27	4626-4627	.	_	_	_	_

#Text=The overriding message from this review is that with respect to particular groups of microorganisms , they cannot all be considered as a single entity and “ one size does not fit all ” when it comes to treatment regimens .
31-1	4628-4631	The	abstract[225]	new[225]	_	_
31-2	4632-4642	overriding	abstract[225]	new[225]	_	_
31-3	4643-4650	message	abstract[225]	new[225]	_	_
31-4	4651-4655	from	abstract[225]	new[225]	_	_
31-5	4656-4660	this	abstract[225]|abstract[226]	new[225]|new[226]	_	_
31-6	4661-4667	review	abstract[225]|abstract[226]	new[225]|new[226]	_	_
31-7	4668-4670	is	_	_	_	_
31-8	4671-4675	that	_	_	_	_
31-9	4676-4680	with	_	_	_	_
31-10	4681-4688	respect	_	_	_	_
31-11	4689-4691	to	_	_	_	_
31-12	4692-4702	particular	animal[227]	new[227]	_	_
31-13	4703-4709	groups	animal[227]	new[227]	_	_
31-14	4710-4712	of	animal[227]	new[227]	_	_
31-15	4713-4727	microorganisms	animal[227]|abstract	new[227]|giv	_	_
31-16	4728-4729	,	_	_	_	_
31-17	4730-4734	they	place	giv	_	_
31-18	4735-4741	cannot	_	_	_	_
31-19	4742-4745	all	_	_	_	_
31-20	4746-4748	be	_	_	_	_
31-21	4749-4759	considered	_	_	_	_
31-22	4760-4762	as	_	_	_	_
31-23	4763-4764	a	abstract[230]	new[230]	_	_
31-24	4765-4771	single	abstract[230]	new[230]	_	_
31-25	4772-4778	entity	abstract[230]	new[230]	_	_
31-26	4779-4782	and	_	_	_	_
31-27	4783-4784	“	_	_	_	_
31-28	4785-4788	one	abstract[231]	new[231]	_	_
31-29	4789-4793	size	abstract[231]	new[231]	_	_
31-30	4794-4798	does	_	_	_	_
31-31	4799-4802	not	_	_	_	_
31-32	4803-4806	fit	_	_	_	_
31-33	4807-4810	all	place	giv	ana	31-36
31-34	4811-4812	”	_	_	_	_
31-35	4813-4817	when	_	_	_	_
31-36	4818-4820	it	place	giv	_	_
31-37	4821-4826	comes	_	_	_	_
31-38	4827-4829	to	_	_	_	_
31-39	4830-4839	treatment	event|abstract[235]	giv|new[235]	coref	34-25
31-40	4840-4848	regimens	abstract[235]	new[235]	_	_
31-41	4849-4850	.	_	_	_	_

#Text=We have shown that the greater capacity to form biofilm is linked to enhanced virulence and increased resistance to antifungals .
32-1	4851-4853	We	person	giv	ana	34-20
32-2	4854-4858	have	_	_	_	_
32-3	4859-4864	shown	_	_	_	_
32-4	4865-4869	that	_	_	_	_
32-5	4870-4873	the	abstract[237]	giv[237]	coref	34-38[269_237]
32-6	4874-4881	greater	abstract[237]	giv[237]	_	_
32-7	4882-4890	capacity	abstract[237]	giv[237]	_	_
32-8	4891-4893	to	abstract[237]	giv[237]	_	_
32-9	4894-4898	form	abstract[237]	giv[237]	_	_
32-10	4899-4906	biofilm	abstract[237]|object	giv[237]|giv	coref	34-34
32-11	4907-4909	is	_	_	_	_
32-12	4910-4916	linked	_	_	_	_
32-13	4917-4919	to	_	_	_	_
32-14	4920-4928	enhanced	abstract[239]	new[239]	_	_
32-15	4929-4938	virulence	abstract[239]	new[239]	_	_
32-16	4939-4942	and	_	_	_	_
32-17	4943-4952	increased	abstract[240]	new[240]	coref	33-21[0_240]
32-18	4953-4963	resistance	abstract[240]	new[240]	_	_
32-19	4964-4966	to	abstract[240]	new[240]	_	_
32-20	4967-4978	antifungals	abstract[240]|substance	new[240]|new	_	_
32-21	4979-4980	.	_	_	_	_

#Text=Further studies of this yeast , alongside the emerging yeast pathogen C. auris , have demonstrated that biofilm-mediated patterns of resistance also exist for both antiseptics and disinfectants , including sodium hypochlorite .
33-1	4981-4988	Further	abstract[242]	new[242]	_	_
33-2	4989-4996	studies	abstract[242]	new[242]	_	_
33-3	4997-4999	of	abstract[242]	new[242]	_	_
33-4	5000-5004	this	abstract[242]|substance[243]	new[242]|giv[243]	coref	33-10[0_243]
33-5	5005-5010	yeast	abstract[242]|substance[243]	new[242]|giv[243]	_	_
33-6	5011-5012	,	abstract[242]	new[242]	_	_
33-7	5013-5022	alongside	abstract[242]	new[242]	_	_
33-8	5023-5026	the	abstract[242]|plant[245]	new[242]|new[245]	_	_
33-9	5027-5035	emerging	abstract[242]|plant[245]	new[242]|new[245]	_	_
33-10	5036-5041	yeast	abstract[242]|substance|plant[245]	new[242]|giv|new[245]	_	_
33-11	5042-5050	pathogen	abstract[242]|plant[245]	new[242]|new[245]	_	_
33-12	5051-5053	C.	person|substance[247]	giv|new[247]	coref	34-28
33-13	5054-5059	auris	substance[247]	new[247]	_	_
33-14	5060-5061	,	_	_	_	_
33-15	5062-5066	have	_	_	_	_
33-16	5067-5079	demonstrated	_	_	_	_
33-17	5080-5084	that	_	_	_	_
33-18	5085-5101	biofilm-mediated	abstract[248]	new[248]	_	_
33-19	5102-5110	patterns	abstract[248]	new[248]	_	_
33-20	5111-5113	of	abstract[248]	new[248]	_	_
33-21	5114-5124	resistance	abstract[248]|abstract	new[248]|giv	_	_
33-22	5125-5129	also	_	_	_	_
33-23	5130-5135	exist	_	_	_	_
33-24	5136-5139	for	_	_	_	_
33-25	5140-5144	both	substance[250]	new[250]	_	_
33-26	5145-5156	antiseptics	substance[250]	new[250]	_	_
33-27	5157-5160	and	_	_	_	_
33-28	5161-5174	disinfectants	place[251]	new[251]	_	_
33-29	5175-5176	,	place[251]	new[251]	_	_
33-30	5177-5186	including	place[251]	new[251]	_	_
33-31	5187-5193	sodium	place[251]|substance|substance[253]	new[251]|new|new[253]	coref|coref	34-3|34-3[255_253]
33-32	5194-5206	hypochlorite	place[251]|substance[253]	new[251]|new[253]	_	_
33-33	5207-5208	.	_	_	_	_

#Text=Given that sodium hypochlorite ( NaOCl ) and EDTA are principal components of the management of endodontic infections , we hypothesised that root canal treatment failure involving C. albicans may be driven by biofilm heterogeneity resulting in an enhanced ability to withstand treatment and regrow within root canals .
34-1	5209-5214	Given	_	_	_	_
34-2	5215-5219	that	_	_	_	_
34-3	5220-5226	sodium	substance|substance[255]	giv|giv[255]	appos	34-6[0_255]
34-4	5227-5239	hypochlorite	substance[255]	giv[255]	_	_
34-5	5240-5241	(	_	_	_	_
34-6	5242-5247	NaOCl	substance	giv	coref	35-14
34-7	5248-5249	)	_	_	_	_
34-8	5250-5253	and	_	_	_	_
34-9	5254-5258	EDTA	abstract	giv	coref	34-11[258_0]
34-10	5259-5262	are	_	_	_	_
34-11	5263-5272	principal	abstract[258]	giv[258]	coref	35-16[0_258]
34-12	5273-5283	components	abstract[258]	giv[258]	_	_
34-13	5284-5286	of	abstract[258]	giv[258]	_	_
34-14	5287-5290	the	abstract[258]|organization[259]	giv[258]|new[259]	_	_
34-15	5291-5301	management	abstract[258]|organization[259]	giv[258]|new[259]	_	_
34-16	5302-5304	of	abstract[258]|organization[259]	giv[258]|new[259]	_	_
34-17	5305-5315	endodontic	abstract[258]|organization[259]|abstract[260]	giv[258]|new[259]|giv[260]	_	_
34-18	5316-5326	infections	abstract[258]|organization[259]|abstract[260]	giv[258]|new[259]|giv[260]	_	_
34-19	5327-5328	,	_	_	_	_
34-20	5329-5331	we	person	giv	ana	35-1
34-21	5332-5344	hypothesised	_	_	_	_
34-22	5345-5349	that	_	_	_	_
34-23	5350-5354	root	place[262]|event[264]	giv[262]|new[264]	_	_
34-24	5355-5360	canal	place[262]|event[264]	giv[262]|new[264]	_	_
34-25	5361-5370	treatment	event|event[264]	giv|new[264]	coref	34-43
34-26	5371-5378	failure	event[264]	new[264]	_	_
34-27	5379-5388	involving	event[264]	new[264]	_	_
34-28	5389-5391	C.	event[264]|person|plant[266]	new[264]|giv|giv[266]	_	_
34-29	5392-5400	albicans	event[264]|plant[266]	new[264]|giv[266]	_	_
34-30	5401-5404	may	_	_	_	_
34-31	5405-5407	be	_	_	_	_
34-32	5408-5414	driven	_	_	_	_
34-33	5415-5417	by	_	_	_	_
34-34	5418-5425	biofilm	object|abstract[268]	giv|giv[268]	coref	35-8
34-35	5426-5439	heterogeneity	abstract[268]	giv[268]	_	_
34-36	5440-5449	resulting	abstract[268]	giv[268]	_	_
34-37	5450-5452	in	abstract[268]	giv[268]	_	_
34-38	5453-5455	an	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-39	5456-5464	enhanced	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-40	5465-5472	ability	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-41	5473-5475	to	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-42	5476-5485	withstand	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-43	5486-5495	treatment	abstract[268]|abstract[269]|event	giv[268]|giv[269]|giv	_	_
34-44	5496-5499	and	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-45	5500-5506	regrow	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
34-46	5507-5513	within	_	_	_	_
34-47	5514-5518	root	place[271]	giv[271]	_	_
34-48	5519-5525	canals	place[271]	giv[271]	_	_
34-49	5526-5527	.	_	_	_	_

#Text=We therefore aimed to assess how different biofilm phenotypes responded in vitro to NaOCl and EDTA treatments .
35-1	5528-5530	We	person	giv	_	_
35-2	5531-5540	therefore	_	_	_	_
35-3	5541-5546	aimed	_	_	_	_
35-4	5547-5549	to	_	_	_	_
35-5	5550-5556	assess	_	_	_	_
35-6	5557-5560	how	_	_	_	_
35-7	5561-5570	different	abstract[274]	new[274]	_	_
35-8	5571-5578	biofilm	object|abstract[274]	giv|new[274]	_	_
35-9	5579-5589	phenotypes	abstract[274]	new[274]	_	_
35-10	5590-5599	responded	_	_	_	_
35-11	5600-5602	in	_	_	_	_
35-12	5603-5608	vitro	organization	new	_	_
35-13	5609-5611	to	_	_	_	_
35-14	5612-5617	NaOCl	substance|abstract[278]	giv|new[278]	_	_
35-15	5618-5621	and	abstract[278]	new[278]	_	_
35-16	5622-5626	EDTA	abstract|abstract[278]	giv|new[278]	_	_
35-17	5627-5637	treatments	abstract[278]	new[278]	_	_
35-18	5638-5639	.	_	_	_	_
